Evidence map›Paper›PMID 33623096›Full record

ArticleScientific reports2021

Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients.

Ka-Chun Un, Chun-Ka Wong, Yuk-Ming Lau, Jeffrey Chun-Yin Lee, Frankie Chor-Cheung Tam, Wing-Hon Lai, Yee-Man Lau, Hao Chen, Sandi Wibowo, Xiaozhu Zhang and 10 more

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ka-Chun Un *Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Chun-Ka Wong *Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Yuk-Ming LauCardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Jeffrey Chun-Yin LeeCardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Frankie Chor-Cheung TamCardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Wing-Hon LaiCardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Yee-Man LauCardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Hao ChenBiofourmis Singapore Pte. Ltd, Singapore, Singapore.
Sandi WibowoBiofourmis Singapore Pte. Ltd, Singapore, Singapore.
Xiaozhu ZhangBiofourmis Singapore Pte. Ltd, Singapore, Singapore.
Minghao YanBiofourmis Singapore Pte. Ltd, Singapore, Singapore.
Esther WuBiofourmis Singapore Pte. Ltd, Singapore, Singapore.
Soon-Chee ChanBiofourmis Singapore Pte. Ltd, Singapore, Singapore.
Sze-Ming LeeHarmony Medical Inc, Hong Kong SAR, China.
Augustine ChowHarmony Medical Inc, Hong Kong SAR, China.
Raymond Cheuk-Fung TongHarmony Medical Inc, Hong Kong SAR, China.
Maulik D MajmudarBiofourmis Singapore Pte. Ltd, Singapore, Singapore.
Kuldeep Singh RajputBiofourmis Singapore Pte. Ltd, Singapore, Singapore.
Ivan Fan-Ngai HungInfectious Diseases Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Chung-Wah SiuCardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China. cwdsiu@hku.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients infected with SARS-CoV-2 may deteriorate rapidly and therefore continuous monitoring is necessary. We conducted an observational study involving patients with mild COVID-19 to explore the potentials of wearable biosensors and machine learning-based analysis of physiology parameters to detect clinical deterioration. Thirty-four patients (median age: 32 years; male: 52.9%) with mild COVID-19 from Queen Mary Hospital were recruited. The mean National Early Warning Score 2 (NEWS2) were 0.59 ± 0.7. 1231 manual measurement of physiology parameters were performed during hospital stay (median 15 days). Physiology parameters obtained from wearable biosensors correlated well with manual measurement including pulse rate (r = 0.96, p < 0.0001) and oxygen saturation (r = 0.87, p < 0.0001). A machine learning-derived index reflecting overall health status, Biovitals Index (BI), was generated by autonomous analysis of physiology parameters, symptoms, and other medical data. Daily BI was linearly associated with respiratory tract viral load (p < 0.0001) and NEWS2 (r = 0.75, p < 0.001). BI was superior to NEWS2 in predicting clinical worsening events (sensitivity 94.1% and specificity 88.9%) and prolonged hospitalization (sensitivity 66.7% and specificity 72.7%). Wearable biosensors coupled with machine learning-derived health index allowed automated detection of clinical deterioration.

Indexed as

COVID-19Machine LearningWearable Electronic DevicesAdultBiosensing TechniquesFemaleHumansMaleMiddle AgedObservational Studies as TopicYoung Adult

Identifiers

PMID33623096
PMCPMC7902655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.